Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.45%
1,101.38
-4.98
-0.45%
—1,106.361,105.681,109.291,096.52——
SIXC
Communications
SIXC
Communications
SIXC
+0.84%
615.40
+5.11
+0.84%
—610.29610.29615.60610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.32%
1,215.11
+3.89
+0.32%
—1,211.221,211.011,220.571,208.50——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.25%
1,755.01
+4.30
+0.25%
—1,750.711,753.101,762.131,743.30——
SIXM
Financials
SIXM
Financials
SIXM
+0.81%
633.27
+5.10
+0.81%
—628.17629.38633.86629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.48%
858.65
+4.08
+0.48%
—854.57855.71859.45855.45——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.07%
217.03
+0.16
+0.07%
—216.87216.87217.79216.17——
SIXT
Technology
SIXT
Technology
SIXT
+1.66%
3,620.95
+59.01
+1.66%
—3,561.943,571.443,628.583,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.01%
903.38
+0.070
+0.01%
—903.31903.26906.56901.18——
SIXV
Health care
SIXV
Health care
SIXV
+0.16%
1,483.96
+2.42
+0.16%
—1,481.541,482.481,488.461,474.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.52%
2,412.45
+12.50
+0.52%
—2,399.952,404.452,412.722,398.09——
AMPH:NASDAQ
Amphastar Pharmaceuticals, Inc
$17.68
-3.49%
(-0.64) 1D
May 14, 12:00:44 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AMPH...
Open
$17.81
High
$18.08
Low
$17.52
Mkt. cap
778.46M
Avg. vol.
554.16K
Volume
260.16K
P/E ratio
10.60
52-wk high
$31.26
52-wk low
$17.03
EPS
$1.67
Beta
0.97
Shares outstanding
44.09M
No. of employees
2K
News stories
From sources across the web
Profile
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products. One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around $20 to $40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally. In March 2018, the company won a patent infringement lawsuit brought against it by Momenta Pharmaceuticals and Sandoz Inc in an ongoing antitrust case. In April 2023, Amphastar Pharmaceuticals bought Baqsimi from Eli Lilly in a deal worth over $1bn. Wikipedia
About Amphastar Pharmaceuticals, Inc
CEO-
Employees1.98K
Founded1996
HeadquartersRancho Cucamonga, California, United States
SectorPharmaceutical industry
Websiteamphastar.com
Last report
May 7, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
$0.42 / $0.73
-42.70%miss
Revenue / Est. (USD)
171.17M / 174.91M
-2.14%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
174.41M
191.84M
183.10M
171.17M
Cost of goods sold
87.92M
93.19M
97.44M
100.85M
Cost of revenue
87.92M
93.19M
97.44M
100.85M
Research and development expenses
20.08M
22.35M
23.31M
26.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.23M
27.87M
26.75M
29.96M
Operating expense
44.31M
50.23M
50.06M
56.69M
Total operating expenses
132.23M
143.42M
147.50M
157.54M
Operating income
42.18M
48.42M
35.61M
13.63M
Other non operating income
-189.00K
231.00K
215.00K
-1.42M
EBT including unusual items
39.34M
21.51M
31.91M
10.05M
EBT excluding unusual items
39.34M
44.61M
31.91M
10.05M
Income tax expense
8.30M
4.16M
7.48M
3.63M
Effective tax rate
21.11%
19.35%
23.45%
36.13%
Other operating expenses
-
-
-
-
Net income
31.03M
17.35M
24.43M
6.42M
Net profit margin
17.79%
9.04%
13.34%
3.75%
Earnings per share
0.85
0.93
0.73
0.42
Interest and investment income
1.92M
2.25M
2.42M
2.40M
Interest expense
-4.58M
-6.28M
-6.33M
-4.55M
Net interest expenses
-2.66M
-4.04M
-3.91M
-2.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
56.80M
62.55M
49.95M
27.98M
Gain or loss from assets sale
30.00K
1.00K
6.00K
4.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer